08 September 2020>: Clinical Research
Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation
Zefeng Wang 1ACDE , Liting Cheng 1BCD , Junmeng Zhang 1AD , Zhuo Liang 1CD , Ruiqing Dong 2B , Fei Hang 1B , Xinlu Wang 1B , Ziyu Wang 1B , Yongquan Wu 1AD* , Jie Du 3ADE*DOI: 10.12659/MSM.926221
Med Sci Monit 2020; 26:e926221
Table 3 Multivariate relationships of LA LVZ.
Variables | OR | β | P |
---|---|---|---|
Age (years) | 1.039 [0.984–1.097] | 0.039 | 0.163 |
eGFR, mol/L | 1.021 [0.996–1.046] | 0.021 | 0.101 |
GLU, mmol/L | 0.716 [0.442–1.158] | −0.335 | 0.173 |
EF,% | 0.274 [0.000–685.477] | −1.294 | 0.746 |
sST2, ng/ml | 1.611 [1.379–1.882] | 0.477 | |
LA – left atrial; OR – odds ratio; sST2 – soluble ST2. |